FibroBiologics Announces Grant of European Patent for Methods of Enhancing Fibroblast Therapeutic Activity

Newly Granted Patent Covers Methods of Augmenting the Regenerative Efficacy of Fibroblasts Using Platelet Rich Plasma and Cytokines, with Claims Directed to Angiogenesis and Spinal Disc RegenerationHOUSTON, Sept. 29, 2026 // -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics" or the…